BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12800369)

  • 21. Solution formulation for continuous flow peritoneal dialysis.
    Diaz-Buxo JA
    Contrib Nephrol; 2003; (140):309-17. PubMed ID: 12800373
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical effects of bicarbonate-based peritoneal fluid.
    Feriani M
    Contrib Nephrol; 2003; (140):70-5. PubMed ID: 12800345
    [No Abstract]   [Full Text] [Related]  

  • 23. Automated peritoneal dialysis technology.
    Dell'Aquila R; Rodighiero MP; Bonello M; Ronco C
    Contrib Nephrol; 2003; (140):278-93. PubMed ID: 12800370
    [No Abstract]   [Full Text] [Related]  

  • 24. [The place of peritoneal dialysis in the treatment of chronic kidney failure].
    Anashkina VR; Kutyrov VO
    Ter Arkh; 1994; 66(6):78-81. PubMed ID: 7940379
    [No Abstract]   [Full Text] [Related]  

  • 25. Biological markers in peritoneal effluent: are they useful?
    Krediet RT
    Contrib Nephrol; 2003; (140):30-7. PubMed ID: 12800341
    [No Abstract]   [Full Text] [Related]  

  • 26. [Continuous ambulatory peritoneal dialysis, CAPD. 18-month experience with a new form of treatment of chronic renal failure].
    Ekelund B; Jørgensen JI
    Ugeskr Laeger; 1982 Sep; 144(38):2776-9. PubMed ID: 7157503
    [No Abstract]   [Full Text] [Related]  

  • 27. Continuous ambulatory peritoneal dialysis (CAPD).
    Mulgaonkar S; Lyman N; Viscuso R; Jacobs MG
    J Med Soc N J; 1983 Jun; 80(6):427-30. PubMed ID: 6577192
    [No Abstract]   [Full Text] [Related]  

  • 28. [Continuous ambulatory peritoneal dialysis in treating chronic kidney failure].
    Robeva R; Belovezhdov N
    Vutr Boles; 1981; 20(4):9-13. PubMed ID: 7029909
    [No Abstract]   [Full Text] [Related]  

  • 29. [Continuous ambulatory peritoneal dialysis: 3 years' experience].
    Ryckelynck JP; Peny J; Landru I; Batho JM; Beuve-Mery P
    LARC Med; 1982 Oct; 2(9):732, 735-9. PubMed ID: 6819418
    [No Abstract]   [Full Text] [Related]  

  • 30. [Automated peritoneal dialysis: impact on residual kidney function and peritoneal membrane permeability].
    Gallar P; Ortega O; Gutiérrez M; Carreño A; Domínguez-Gil B; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2001; 21(2):200-3. PubMed ID: 11464654
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment failure in automated peritoneal dialysis and double-bag continuous ambulatory peritoneal dialysis.
    Katavetin P; Theerasin Y; Treamtrakanpon W; Saiprasertkit N; Kanjanabuch T
    Nephrology (Carlton); 2013 Aug; 18(8):545-8. PubMed ID: 23730742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. At-home dialysis: consider the advantages.
    Johns Hopkins Med Lett Health After 50; 2004 Nov; 17(9):3, 7. PubMed ID: 15609440
    [No Abstract]   [Full Text] [Related]  

  • 33. Membrane viability in the long-term peritoneal dialysis patient.
    Schreiber MJ
    Perit Dial Int; 1997; 17 Suppl 3():S19-24. PubMed ID: 9304652
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of residual renal function on the adequacy of peritoneal dialysis.
    Lameire N; Van Biesen W
    Perit Dial Int; 1997; 17 Suppl 2():S102-10. PubMed ID: 9163808
    [No Abstract]   [Full Text] [Related]  

  • 35. Peritoneal dialysis.
    Teitelbaum I; Burkart J
    Am J Kidney Dis; 2003 Nov; 42(5):1082-96. PubMed ID: 14582053
    [No Abstract]   [Full Text] [Related]  

  • 36. Peritoneal dialysis in diabetic patients.
    Bertoli M; Bonfante L; Gambaro G; Cara M; Virgilio B; D'Angelo A
    Contrib Nephrol; 2001; (131):51-60. PubMed ID: 11125563
    [No Abstract]   [Full Text] [Related]  

  • 37. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of infections in peritoneal dialysis.
    Shetty H; Gokal R
    Contrib Nephrol; 2003; (140):187-94. PubMed ID: 12800359
    [No Abstract]   [Full Text] [Related]  

  • 39. Targets in CAPD and APD prescription.
    Blake PG
    Perit Dial Int; 1996; 16 Suppl 1():S143-6. PubMed ID: 8728181
    [No Abstract]   [Full Text] [Related]  

  • 40. Peritoneal dialysis maintains patients' freedom for years.
    Oreopoulos D; Sombolos K
    Dimens Health Serv; 1985 Dec; 62(10):14-6. PubMed ID: 4076559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.